Insider Trading activities at Pacira Biosciences, Inc. (PCRX) , Part 2

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Pacira Biosciences, Inc. (PCRX) since 2015 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Pacira Biosciences, Inc.. (See page 1 of this report.) Table 2 shows the detailed insider transactions. This company's CIK number is 1396814.

Total stock buying since 2015: $1,511,746.
Total stock sales since 2015: $134,046,095.
Total stock option exercises since 2015: $25,248,807.


 1   2 
29 insiders reported insider trading activities at Pacira Biosciences, Inc. (PCRX):
Insider trading activities of Stack David M
Insider trading activities of Brege Laura
Insider trading activities of Reinhardt Max
Insider trading activities of Braunstein Scott
Insider trading activities of Kronenfeld Mark A.
Insider trading activities of Molloy Anthony
Insider trading activities of Longenecker John P Phd
Insider trading activities of Hastings Paul J
Insider trading activities of Winston Roy
Insider trading activities of Slonin Jonathan
Insider trading activities of Weiland Robert J.
Insider trading activities of Williams Kristen Marie
Insider trading activities of Reinhart Charles A. Iii
Insider trading activities of Markvicka Taunia
Insider trading activities of Pace Gary W
Insider trading activities of Bigal Marcelo
Insider trading activities of Jones James B
Insider trading activities of Riker Lauren Bullaro
Insider trading activities of Gaugler Daryl
Insider trading activities of Scranton Richard
Insider trading activities of Manning Donald C.
Insider trading activities of Froimson Mark
Insider trading activities of Wicki Andreas
Insider trading activities of Yang Michael J.
Insider trading activities of Laranjeira Charles Anthony
Insider trading activities of Lee Frank D.
Insider trading activities of Ellis Ronald J. Jr.
Insider trading activities of Scibetta James S
Insider trading activities of Mcloughlin Dennis

Table 1. Yearly summary of insider stock purchases, sales, and option exercises at Pacira Biosciences, Inc. (PCRX).
Insider Buying Insider Sales Option Exercises
Year Shares Value Shares Value Shares Value
2025 0 $0 20,833 $539,598 0 $0
2024 17,576 $215,684 142,418 $4,293,651 0 $0
2023 0 $0 75,177 $2,936,447 23,500 $712,900
2022 0 $0 227,928 $15,306,874 252,372 $6,507,813
2021 0 $0 400,927 $28,062,960 167,093 $3,407,228
2020 2,500 $91,250 691,456 $39,746,803 478,835 $10,972,788
2019 1,700 $66,181 180,507 $7,746,578 158,807 $1,273,560
2018 9,500 $457,581 284,591 $12,905,232 126,976 $559,010
2017 1,100 $45,316 190,915 $7,882,924 173,811 $872,627
2016 3,800 $235,054 122,574 $6,058,768 148,000 $484,035
2015 6,000 $400,680 104,000 $8,566,260 112,349 $458,846


Table 3. Detailed insider trading at Pacira Biosciences, Inc. (PCRX) , Part 2
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2021-03-15 Riker Lauren Bullaro (Vice President, Finance) Option Ex 1,520 10.81 16,431
2021-03-15 Wicki Andreas Sale 10,601 73.68 781,081
2021-03-12 Wicki Andreas Sale 58,754 73.10 4,294,917
2021-03-11 Wicki Andreas Sale 60,574 72.70 4,403,729
2021-03-10 Wicki Andreas Sale 76,480 71.78 5,489,734
2021-03-09 Wicki Andreas Sale 35,137 70.90 2,491,213
2021-03-05 Hastings Paul J (Director) Sale 3,000 65.88 197,640
2021-03-05 Hastings Paul J (Director) Option Ex 3,000 13.98 41,940
2021-03-01 Longenecker John P Phd (Director) Sale 5,000 72.26 361,300
2021-03-01 Longenecker John P Phd (Director) Option Ex 5,000 13.98 69,900
2021-02-03 Stack David M (CEO and Chairman) Sale 21,250 71.10 1,510,874
2021-02-03 Stack David M (CEO and Chairman) Option Ex 21,250 10.81 229,712
2021-02-02 Stack David M (CEO and Chairman) Sale 21,250 69.33 1,473,262
2021-02-02 Stack David M (CEO and Chairman) Option Ex 21,250 10.81 229,712
2021-01-06 Reinhardt Max (President) Sale 110 60.81 6,689
2020-11-16 Brege Laura (Director) Sale 12,000 65.95 791,400
2020-11-16 Brege Laura (Director) Option Ex 12,000 13.98 167,760
2020-11-13 Reinhardt Max (President) Sale 25,000 63.09 1,577,250
2020-11-13 Reinhardt Max (President) Option Ex 25,000 42.54 1,063,500
2020-11-13 Winston Roy (Chief Clinical Officer) Sale 5,000 62.00 310,000
2020-11-13 Riker Lauren Bullaro (Vice President, Finance) Sale 3,000 63.81 191,430
2020-11-13 Riker Lauren Bullaro (Vice President, Finance) Option Ex 3,000 10.81 32,430
2020-10-16 Stack David M (CEO and Chairman) Sale 30,000 55.56 1,666,800
2020-10-16 Stack David M (CEO and Chairman) Option Ex 30,000 10.81 324,300
2020-10-15 Stack David M (CEO and Chairman) Sale 30,000 55.00 1,650,000
2020-10-15 Stack David M (CEO and Chairman) Option Ex 30,000 10.81 324,300
2020-10-14 Stack David M (CEO and Chairman) Sale 30,000 55.53 1,665,900
2020-10-14 Stack David M (CEO and Chairman) Option Ex 30,000 10.81 324,300
2020-09-25 Pace Gary W (Director) Option Ex 70,000 16.67 1,166,900
2020-09-17 Reinhardt Max (President) Sale 25,420 60.01 1,525,327
2020-09-17 Reinhardt Max (President) Option Ex 25,000 42.54 1,063,500
2020-09-17 Williams Kristen Marie (Chief Administrative Officer) Sale 27,871 59.99 1,672,120
2020-09-17 Williams Kristen Marie (Chief Administrative Officer) Option Ex 27,871 39.76 1,108,039
2020-09-16 Riker Lauren Bullaro (Vice President, Finance) Sale 3,000 60.34 181,020
2020-09-16 Riker Lauren Bullaro (Vice President, Finance) Option Ex 3,000 10.81 32,430
2020-09-16 Williams Kristen Marie (Chief Administrative Officer) Sale 27,853 59.94 1,669,369
2020-09-16 Williams Kristen Marie (Chief Administrative Officer) Option Ex 27,853 39.76 1,107,323
2020-09-15 Williams Kristen Marie (Chief Administrative Officer) Sale 27,853 59.41 1,654,607
2020-09-15 Williams Kristen Marie (Chief Administrative Officer) Option Ex 27,853 39.76 1,107,323
2020-09-09 Wicki Andreas (Director) Sale 2,216 62.02 137,436
2020-08-17 Stack David M (CEO and Chairman) Sale 15,000 62.06 930,975
2020-08-13 Wicki Andreas (Director) Sale 34,904 61.47 2,145,548
2020-08-12 Wicki Andreas (Director) Sale 113,500 60.82 6,903,070
2020-08-11 Riker Lauren Bullaro (Vice President, Finance) Sale 8,180 60.50 494,890
2020-08-11 Riker Lauren Bullaro (Vice President, Finance) Option Ex 8,180 10.34 84,581
2020-08-11 Wicki Andreas (Director) Sale 106,772 61.38 6,554,199
2020-08-03 Laranjeira Charles Anthony (SVP, Technical Operations) Sale 2,500 52.68 131,700
2020-08-03 Laranjeira Charles Anthony (SVP, Technical Operations) Option Ex 2,500 44.10 110,250
2020-07-15 Stack David M (CEO and Chairman) Sale 12,000 56.88 682,560
2020-06-29 Riker Lauren Bullaro (Vice President, Finance) Sale 6,000 49.47 296,802
2020-06-29 Riker Lauren Bullaro (Vice President, Finance) Option Ex 6,000 10.34 62,040
2020-06-29 Laranjeira Charles Anthony (SVP, Technical Operations) Sale 60,101 51.27 3,081,378
2020-06-29 Laranjeira Charles Anthony (SVP, Technical Operations) Option Ex 56,250 40.95 2,303,437
2020-06-08 Stack David M (CEO and Chairman) Sale 17,111 48.28 826,204
2020-06-05 Riker Lauren Bullaro (Vice President, Finance) Sale 1,752 48.37 84,744
2020-06-05 Brege Laura (Director) Sale 2,100 48.70 102,270
2020-06-05 Williams Kristen Marie (Chief Administrative Officer) Sale 5,904 48.61 286,993
2020-06-04 Mcloughlin Dennis (Chief Commercial Officer) Sale 1,447 46.33 67,040
2020-06-04 Riker Lauren Bullaro (Vice President, Finance) Sale 879 46.33 40,724
2020-06-04 Laranjeira Charles Anthony (SVP, Technical Operations) Sale 863 46.33 39,983
2020-06-04 Reinhart Charles A. Iii (Chief Financial Officer) Sale 1,489 46.33 68,986
2020-06-04 Hastings Paul J (Director) Sale 2,025 47.46 96,106
2020-06-04 Williams Kristen Marie (Chief Administrative Officer) Sale 2,402 46.33 111,287
2020-06-04 Stack David M (CEO and Chairman) Sale 14,314 46.33 663,181
2020-05-21 Riker Lauren Bullaro (Vice President, Finance) Sale 2,000 45.26 90,520
2020-05-21 Riker Lauren Bullaro (Vice President, Finance) Option Ex 2,000 10.34 20,680
2020-05-19 Riker Lauren Bullaro (Vice President, Finance) Sale 2,000 42.81 85,620
2020-05-19 Riker Lauren Bullaro (Vice President, Finance) Option Ex 2,000 10.34 20,680
2020-03-12 Longenecker John P Phd (Director) Option Ex 3,736 1.61 6,014
2020-03-12 Pace Gary W (Director) Option Ex 21,736 4.70 102,224
2020-03-11 Winston Roy (Chief Clinical Officer) Buy 2,500 36.50 91,250
2020-02-21 Stack David M (CEO and Chairman) Option Ex 35,856 3.55 127,288
2020-02-10 Riker Lauren Bullaro (Vice President, Finance) Sale 3,000 48.81 146,430
2020-02-10 Riker Lauren Bullaro (Vice President, Finance) Option Ex 3,000 10.81 32,430
2020-02-07 Riker Lauren Bullaro (Vice President, Finance) Sale 170 46.81 7,957
2020-02-07 Riker Lauren Bullaro (Vice President, Finance) Option Ex 170 10.81 1,837
2020-02-06 Riker Lauren Bullaro (Vice President, Finance) Sale 830 46.81 38,852
2020-02-06 Riker Lauren Bullaro (Vice President, Finance) Option Ex 830 10.81 8,972
2020-01-15 Stack David M (CEO and Chairman) Sale 25,000 43.05 1,076,125
2020-01-15 Stack David M (CEO and Chairman) Option Ex 25,000 10.81 270,250
2019-12-26 Stack David M (CEO and Chairman) Option Ex 20,000 3.55 71,000
2019-12-23 Riker Lauren Bullaro (Vice President, Finance) Sale 1,000 45.92 45,920
2019-12-23 Riker Lauren Bullaro (Vice President, Finance) Option Ex 1,000 10.81 10,810
2019-12-16 Mcloughlin Dennis (Chief Commercial Officer) Sale 3,671 45.79 168,109
2019-12-02 Longenecker John P Phd (Director) Sale 1,300 46.13 59,971
2019-12-02 Longenecker John P Phd (Director) Option Ex 4,000 1.61 6,440
2019-11-20 Riker Lauren Bullaro (Vice President, Finance) Sale 1,176 44.14 51,908
2019-11-20 Riker Lauren Bullaro (Vice President, Finance) Option Ex 1,000 10.81 10,810
2019-11-15 Stack David M (CEO and Chairman) Sale 70,000 42.81 2,996,700
2019-11-15 Stack David M (CEO and Chairman) Option Ex 25,000 10.81 270,250
2019-11-11 Riker Lauren Bullaro (Vice President, Finance) Sale 5,000 43.59 217,950
2019-11-11 Riker Lauren Bullaro (Vice President, Finance) Option Ex 5,000 10.57 52,875
2019-11-08 Scranton Richard (Chief Scientific Officer) Sale 19,448 45.00 875,160
2019-11-08 Scranton Richard (Chief Scientific Officer) Option Ex 19,448 18.09 351,814
2019-10-02 Stack David M (CEO and Chairman) Option Ex 17,000 3.55 60,350
2019-09-18 Stack David M (CEO and Chairman) Option Ex 14,000 3.55 49,700
2019-08-15 Stack David M (CEO and Chairman) Sale 12,849 39.33 505,351
2019-08-15 Stack David M (CEO and Chairman) Option Ex 12,849 10.81 138,897
2019-08-14 Williams Kristen Marie (Chief Administrative Officer) Sale 6,252 39.49 246,891
2019-07-08 Stack David M (CEO and Chairman) Sale 13,115 43.13 565,715
2019-06-11 Stack David M (CEO and Chairman) Option Ex 24,000 3.55 85,200
2019-06-10 Riker Lauren Bullaro (Vice President, Finance) Sale 2,126 44.28 94,139
2019-06-05 Scranton Richard (Chief Scientific Officer) Sale 4,114 43.50 178,959
2019-06-04 Mcloughlin Dennis (Chief Commercial Officer) Sale 1,099 42.91 47,158
2019-06-04 Winston Roy (Chief Clinical Officer) Sale 722 42.91 30,981
2019-06-04 Scranton Richard (Chief Scientific Officer) Sale 4,926 42.78 210,758
2019-06-04 Riker Lauren Bullaro (Vice President, Finance) Sale 967 42.91 41,493
2019-06-04 Laranjeira Charles Anthony (SVP, Technical Operations) Sale 430 42.91 18,451
2019-06-04 Reinhart Charles A. Iii (Chief Financial Officer) Sale 1,106 42.91 47,458
2019-06-04 Hastings Paul J (Director) Sale 782 42.66 33,360
2019-06-04 Williams Kristen Marie (CAO and General Counsel) Sale 2,529 42.91 108,519
2019-06-04 Stack David M (CEO and Chairman) Sale 12,385 42.91 531,440
2019-06-03 Scranton Richard (Chief Scientific Officer) Sale 15,510 43.21 670,187
2019-06-03 Scranton Richard (Chief Scientific Officer) Option Ex 15,510 10.66 165,414
2019-03-06 Kronenfeld Mark A. (Director) Buy 1,700 38.93 66,181
2018-12-18 Stack David M (CEO and Chairman) Option Ex 12,000 3.55 42,600
2018-12-13 Wicki Andreas Sale 8,720 46.18 402,689
2018-12-12 Wicki Andreas Sale 5,807 47.84 277,801
2018-11-19 Wicki Andreas Sale 990 47.08 46,605
2018-11-19 Pace Gary W (Director) Buy 4,500 46.18 207,810
2018-11-16 Wicki Andreas Sale 25,600 46.93 1,201,356
2018-11-15 Wicki Andreas Sale 44,898 47.64 2,138,850
2018-11-15 Stack David M (CEO and Chairman) Sale 15,000 47.48 712,125
2018-11-12 Wicki Andreas Sale 5,478 49.83 272,979
2018-11-09 Wicki Andreas Sale 906 50.23 45,508
2018-11-08 Wicki Andreas Sale 57,339 51.13 2,931,571
2018-11-07 Pace Gary W (Director) Buy 4,000 51.29 205,160
2018-11-02 Riker Lauren Bullaro (Vice President, Finance) Sale 1,000 54.35 54,350
2018-11-02 Riker Lauren Bullaro (Vice President, Finance) Option Ex 1,000 10.34 10,340
2018-10-11 Stack David M (CEO and Chairman) Option Ex 45,000 2.90 130,635
2018-09-24 Riker Lauren Bullaro (Vice President, Finance) Sale 1,000 50.70 50,700
2018-09-24 Riker Lauren Bullaro (Vice President, Finance) Option Ex 1,000 10.34 10,340
2018-08-28 Kronenfeld Mark A. (Director) Buy 1,000 44.61 44,611
2018-08-22 Riker Lauren Bullaro (Vice President, Finance) Sale 1,667 44.48 74,148
2018-08-15 Stack David M (CEO and Chairman) Sale 33,062 47.40 1,567,138
2018-08-15 Stack David M (CEO and Chairman) Option Ex 14,091 8.15 114,841
2018-08-14 Williams Kristen Marie (CAO and General Counsel) Sale 4,773 47.04 224,521
2018-06-07 Stack David M (CEO and Chairman) Sale 9,791 37.08 363,050
2018-06-06 Stack David M (CEO and Chairman) Sale 8,615 35.61 306,780
2018-06-04 Scranton Richard (Chief Scientific Officer) Sale 1,367 33.02 45,138
2018-06-04 Weiland Robert J. (Chief Commercial Officer) Sale 373 33.02 12,316
2018-06-04 Riker Lauren Bullaro (Vice President, Finance) Sale 801 33.02 26,449
2018-06-04 Reinhart Charles A. Iii (Chief Financial Officer) Sale 708 33.02 23,378
2018-06-04 Hastings Paul J (Director) Sale 771 33.90 26,136
2018-06-04 Williams Kristen Marie (CAO and General Counsel) Sale 2,040 33.02 67,360
2018-05-15 Stack David M (CEO and Chairman) Sale 25,000 34.02 850,375
2018-05-15 Stack David M (CEO and Chairman) Option Ex 25,000 8.15 203,750
2018-01-10 Stack David M (CEO and Chairman) Sale 28,885 40.99 1,183,909
2018-01-10 Stack David M (CEO and Chairman) Option Ex 28,885 1.61 46,504
2017-12-15 Riker Lauren Bullaro (Vice President, Finance) Sale 340 43.70 14,858
2017-11-20 Jones James B (SVP & Chief Medical Officer) Sale 850 41.11 34,942
2017-11-17 Williams Kristen Marie (CAO and General Counsel) Sale 7,857 40.00 314,280
2017-11-17 Williams Kristen Marie (CAO and General Counsel) Option Ex 7,857 25.37 199,332
2017-11-16 Williams Kristen Marie (CAO and General Counsel) Sale 2,143 40.01 85,741
2017-11-16 Williams Kristen Marie (CAO and General Counsel) Option Ex 2,143 25.37 54,367
2017-11-15 Stack David M (CEO and Chairman) Sale 58,885 38.65 2,275,610
2017-11-15 Stack David M (CEO and Chairman) Option Ex 28,885 1.61 46,504
2017-11-10 Kronenfeld Mark A. (Director) Buy 1,000 41.60 41,603
2017-08-22 Hastings Paul J (Director) Sale 1,044 36.15 37,740
2017-08-15 Williams Kristen Marie (CAO and General Counsel) Sale 3,461 36.75 127,191
2017-08-15 Stack David M (CEO and Chairman) Sale 28,885 36.37 1,050,547
2017-08-15 Stack David M (CEO and Chairman) Option Ex 28,885 1.61 46,504
2017-08-08 Froimson Mark (Director) Buy 100 37.13 3,713
2017-07-24 Stack David M (CEO and Chairman) Option Ex 15,000 1.61 24,150
2017-06-23 Stack David M (CEO and Chairman) Option Ex 15,000 1.61 24,150
2017-06-07 Riker Lauren Bullaro (Vice President, Finance) Sale 1,119 44.37 49,650
2017-06-05 Jones James B (SVP & Chief Medical Officer) Sale 767 43.32 33,227
2017-06-05 Braunstein Scott (SVP, Strategy & Corp. Dev.) Sale 768 43.32 33,270
2017-06-05 Riker Lauren Bullaro (Vice President, Finance) Sale 601 43.32 26,035
2017-06-05 Scibetta James S (President) Sale 1,966 43.32 85,169
2017-06-05 Williams Kristen Marie (CAO and General Counsel) Sale 1,877 43.32 81,313
2017-06-05 Stack David M (CEO and Chairman) Sale 4,311 43.32 186,756
2017-05-15 Scibetta James S (President) Sale 20,000 51.20 1,024,000
2017-05-15 Scibetta James S (President) Option Ex 20,000 5.49 109,800
2017-05-15 Williams Kristen Marie (CAO and General Counsel) Sale 21,041 50.86 1,070,145
2017-05-15 Williams Kristen Marie (CAO and General Counsel) Option Ex 21,041 10.19 214,470
2017-01-17 Scibetta James S (President) Sale 20,000 38.68 773,600
2017-01-17 Scibetta James S (President) Option Ex 20,000 3.55 71,000
2017-01-17 Stack David M (CEO and Chairman) Sale 15,000 38.59 578,850
2017-01-17 Stack David M (CEO and Chairman) Option Ex 15,000 5.49 82,350
2016-11-15 Scibetta James S (President) Sale 20,000 36.50 730,000
2016-11-15 Scibetta James S (President) Option Ex 20,000 1.61 32,200
2016-11-15 Stack David M (CEO and Chairman) Sale 15,000 37.48 562,275
2016-11-15 Stack David M (CEO and Chairman) Option Ex 15,000 5.49 82,350
2016-10-05 Stack David M (CEO and Chairman) Option Ex 30,000 1.61 48,300
2016-08-15 Scibetta James S (President) Sale 25,000 45.21 1,130,250
2016-08-15 Scibetta James S (President) Option Ex 25,000 1.61 40,250
2016-08-15 Stack David M (CEO and Chairman) Sale 15,000 45.32 679,800
2016-08-15 Stack David M (CEO and Chairman) Option Ex 15,000 5.49 82,350
2016-06-07 Riker Lauren Bullaro (Vice President, Finance) Sale 617 47.90 29,554
2016-06-06 Kronenfeld Mark A. (Director) Sale 900 46.95 42,255
2016-06-06 Riker Lauren Bullaro (Vice President, Finance) Sale 321 47.20 15,150
2016-06-06 Brege Laura (Director) Sale 1,000 46.95 46,950
2016-06-06 Hastings Paul J (Director) Sale 1,136 46.95 53,335
2016-06-06 Williams Kristen Marie (CAO and General Counsel) Sale 600 47.20 28,319
2016-04-15 Stack David M (CEO and Chairman) Sale 25,000 64.30 1,607,375
2016-04-15 Stack David M (CEO and Chairman) Option Ex 25,000 5.49 137,250
2016-02-17 Hastings Paul J (Director) Sale 3,000 60.00 180,000
2016-02-17 Hastings Paul J (Director) Option Ex 3,000 12.39 37,185
2016-01-29 Braunstein Scott (SVP, Strategy & Corp. Dev.) Buy 2,000 58.92 117,840
2016-01-27 Jones James B (SVP & Chief Medical Officer) Buy 500 62.50 31,250
2016-01-15 Stack David M (CEO and Chairman) Sale 15,000 63.57 953,505
2016-01-15 Stack David M (CEO and Chairman) Option Ex 15,000 1.61 24,150
2016-01-12 Jones James B (SVP & Chief Medical Officer) Buy 1,000 66.00 66,000
2016-01-12 Longenecker John P Phd (Director) Buy 300 66.55 19,964
2015-11-20 Hastings Paul J (Director) Sale 3,000 60.00 180,000
2015-11-20 Hastings Paul J (Director) Option Ex 3,000 10.81 32,430
2015-10-15 Stack David M (President, CEO and Chairman) Sale 15,000 37.83 567,450
2015-10-15 Stack David M (President, CEO and Chairman) Option Ex 15,000 1.61 24,150
2015-09-11 Scibetta James S (SVP, Chief Financial Officer) Buy 5,000 61.37 306,850
2015-08-17 Hastings Paul J (Director) Sale 3,000 60.02 180,060
2015-08-17 Hastings Paul J (Director) Option Ex 3,000 10.81 32,430
2015-07-15 Stack David M (President, CEO and Chairman) Sale 15,000 67.78 1,016,700
2015-07-15 Stack David M (President, CEO and Chairman) Option Ex 15,000 1.61 24,150
2015-04-15 Stack David M (President, CEO and Chairman) Sale 25,000 90.50 2,262,475
2015-04-15 Stack David M (President, CEO and Chairman) Option Ex 25,000 1.61 40,250
2015-04-10 Hastings Paul J (Director) Sale 2,500 88.00 220,000
2015-04-10 Hastings Paul J (Director) Option Ex 2,500 13.98 34,950
2015-03-17 Markvicka Taunia (SVP, Chief Commercial Officer) Option Ex 8,349 5.49 45,836
2015-03-16 Riker Lauren Bullaro (Executive Director, Finance) Sale 5,000 95.34 476,700
2015-03-16 Riker Lauren Bullaro (Executive Director, Finance) Option Ex 5,000 10.34 51,700
2015-03-13 Pace Gary W (Director) Buy 1,000 93.83 93,830
2015-03-12 Longenecker John P Phd (Director) Sale 3,000 95.28 285,840
2015-03-12 Longenecker John P Phd (Director) Option Ex 3,000 29.90 89,700
2015-02-06 Scibetta James S (SVP, Chief Financial Officer) Sale 15,000 111.54 1,673,130
2015-02-06 Scibetta James S (SVP, Chief Financial Officer) Option Ex 15,000 1.61 24,150
2015-01-15 Stack David M (President, CEO and Chairman) Sale 15,000 97.92 1,468,755
2015-01-15 Stack David M (President, CEO and Chairman) Option Ex 15,000 1.61 24,150
2015-01-12 Hastings Paul J (Director) Sale 2,500 94.06 235,150
2015-01-12 Hastings Paul J (Director) Option Ex 2,500 13.98 34,950
 1   2 

Insider trading activities including stock purchases, stock sales, and option exercises of PCRX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Pacira Biosciences, Inc. (symbol PCRX, CIK number 1396814) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.